Sinomab Bioscience
Shanghai, China· Est.
Sinomab Bioscience focuses on developing monoclonal antibody therapies for autoimmune and inflammatory diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
Sinomab Bioscience focuses on developing monoclonal antibody therapies for autoimmune and inflammatory diseases.
AntibodiesImmunology